947 filings
Page 4 of 48
10-K
2023 FY
ARWR
Arrowhead Pharmaceuticals Inc.
Annual report
29 Nov 23
4:09pm
4
Martin Javier San
22 Nov 23
ARROWHEAD PHARMACEUTICALS / Martin Javier San ownership change
2:31pm
144
Martin Javier San
20 Nov 23
Notice of proposed sale of securities
4:06pm
4
Anzalone Christopher Richard
27 Oct 23
ARROWHEAD PHARMACEUTICALS / Christopher Richard Anzalone ownership change
6:23pm
4
Victoria Vakiener
2 Oct 23
ARROWHEAD PHARMACEUTICALS / Victoria Vakiener ownership change
5:51pm
144
Victoria Vakiener
28 Sep 23
Notice of proposed sale of securities
2:50pm
4
Anzalone Christopher Richard
20 Sep 23
ARROWHEAD PHARMACEUTICALS / Christopher Richard Anzalone ownership change
6:10pm
144
ARWR
Arrowhead Pharmaceuticals Inc.
18 Sep 23
Notice of proposed sale of securities
4:20pm
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
7 Aug 23
Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results
4:10pm
4
ARWR
Arrowhead Pharmaceuticals Inc.
6 Jul 23
ARROWHEAD PHARMACEUTICALS / Tracie Oliver ownership change
6:04pm
4
James C Hamilton
5 Jul 23
ARROWHEAD PHARMACEUTICALS / James C Hamilton ownership change
6:15pm
144
ARWR
Arrowhead Pharmaceuticals Inc.
3 Jul 23
Notice of proposed sale of securities
1:04pm
144
ARWR
Arrowhead Pharmaceuticals Inc.
30 Jun 23
Notice of proposed sale of securities
1:33pm
4
ARWR
Arrowhead Pharmaceuticals Inc.
29 Jun 23
ARROWHEAD PHARMACEUTICALS / Kenneth Allen Myszkowski ownership change
6:41pm
144
ARWR
Arrowhead Pharmaceuticals Inc.
27 Jun 23
Notice of proposed sale of securities
4:01pm
SC 13G/A
ARWR
Arrowhead Pharmaceuticals Inc.
9 Jun 23
ARROWHEAD PHARMACEUTICALS / VANGUARD ownership change
2:15pm
UPLOAD
ARWR
Arrowhead Pharmaceuticals Inc.
19 May 23
Letter from SEC
12:00am
4
Given Douglas B
8 May 23
ARROWHEAD PHARMACEUTICALS / DOUGLAS B GIVEN ownership change
6:29pm
4
ARWR
Arrowhead Pharmaceuticals Inc.
5 May 23
ARROWHEAD PHARMACEUTICALS / Christopher Richard Anzalone ownership change
7:04pm